Ping An Biomedical Co., Ltd.

PASW Consumer Cyclical Textile Manufacturing

Ping An Biomedical Co., Ltd.’s revenue for fiscal 2025 (year ended September 2025) was $4.8 million, down 61.6% from fiscal 2024.

0.12 0.01 −7.69%
Market cap
$16.7M
P/E
—
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
4.30
Beneish M
−2.88
Dividend safety
n/a
Sep '25 Sep '24
Altman Z-Score
4.30 —
Altman Z″-Score (non-manufacturers)
3.50 (1.77)
P/FCF ratio
0.00 0.00
Beneish M-Score
(2.88) —
P/Operating CF
0.00 0.00
P/B ratio
0.00 0.00
EV/Sales
0.00 0.00
EV/EBITDA
0.00 0.00
EV/FCF
0.00 0.00
Current Ratio
2.76 0.84
Net Debt/EBITDA
1.81 1,226.75
Debt/Equity
0.22 (1.46)
ROE
(67.61%) 0.00%
ROA
(20.35%) 0.00%
ROIC
(49.29%) (0.04%)
Return on Tangible Assets
(31.58%) 12.52%
Average Days of Receivables
180.97 168.49
Free Cash Flow Yield
0.00% 0.00%
Free Cash Flow per Share
(0.05) 0.12
Book value per Share
0.34 (0.06)
Free Cash Flow
(0.90) 2.08
EV/EBIT
0.00 0.00
Other line items

Show all line items

Columns are period end dates